A novel risk classifier to predict the in-hospital death risk of nosocomial infections in elderly cancer patients
暂无分享,去创建一个
Xuan Liang | Yuan Yao | N. Zhao | T. Tian | Ai-min Jiang | Z. Ruan | Xiao Fu | Na Liu | Jingjing Wang | Xiao-fang Shang | Yimeng Li | Huan Gao
[1] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[2] Wan-yang Li,et al. Effect of malnutrition and nutritional support to reduce infections in elderly hospitalized patients with cancer: A multicenter survey in China. , 2022, Nutrition.
[3] C. Sprung,et al. Outcomes and predictors of 28-day mortality in patients with solid tumors and septic shock defined by Sepsis-3 criteria. , 2022, Chest.
[4] Yanping Xiao,et al. Association among prognostic nutritional index, post-operative infection and prognosis of stage II/III gastric cancer patients following radical gastrectomy , 2022, European Journal of Clinical Nutrition.
[5] Xuan Liang,et al. Establishment and validation of a nomogram to predict the in-hospital death risk of nosocomial infections in cancer patients , 2022, Antimicrobial Resistance & Infection Control.
[6] C. Sprung,et al. Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] N. Rezaei,et al. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis , 2021, Frontiers in Immunology.
[8] M. Abdullah,et al. A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock , 2021, BMC cancer.
[9] J. Carratalá,et al. Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance , 2021, Frontiers in Medicine.
[10] T. Ozgurtas,et al. A new COVID-19 prediction scoring model for in-hospital mortality: experiences from Turkey, single center retrospective cohort analysis. , 2020, European review for medical and pharmacological sciences.
[11] Rui Zhao,et al. The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and it’s influencing factors: a meta-analysis of observational studies , 2020, Journal of thoracic disease.
[12] Xuan Liang,et al. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China , 2020, BMC Infectious Diseases.
[13] Dongying Chen,et al. Epidemiology and Mortality-Associated Factors of Invasive Fungal Disease in Elderly Patients: A 20-Year Retrospective Study from Southern China , 2020, Infection and drug resistance.
[14] Rui Zhang,et al. Clinical outcomes and prognostic factors in bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a meta-analysis , 2020, Annals of clinical microbiology and antimicrobials.
[15] T. Buchman,et al. Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018* , 2020, Critical care medicine.
[16] T. Buchman,et al. Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018* , 2020, Critical care medicine.
[17] John A. Bohlin,et al. Statistical predictions with glmnet , 2019, Clinical Epigenetics.
[18] J. Carratalá,et al. Current etiology, clinical features and outcomes of bacteremia in older patients with solid tumors. , 2019, Journal of geriatric oncology.
[19] Chang-ming Huang,et al. Does Intra-Abdominal Infection after Curative Gastrectomy Affect Patients' Long-Term Prognosis? A Multi-Center Study Based on a Large Sample Size. , 2019, Surgical infections.
[20] Tingting Zhang,et al. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis. , 2018, Clinica chimica acta; international journal of clinical chemistry.
[21] C. Flowers,et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] P. Hsueh,et al. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013. , 2017, International journal of antimicrobial agents.
[23] A. Oliver,et al. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae , 2017, The Journal of antimicrobial chemotherapy.
[24] Kathleen F. Kerr,et al. Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. Seo,et al. Prevention and treatment of cancer-related infections, version 2.2016 , 2016 .
[26] K. Czene,et al. Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis. , 2016, The Journal of infection.
[27] H. Yoon,et al. Febrile Urinary Tract Infection after Radical Cystectomy and Ileal Neobladder in Patients with Bladder Cancer , 2016, Journal of Korean medical science.
[28] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[29] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[30] J. Aguado,et al. Bloodstream infections in patients with solid tumors , 2016, Virulence.
[31] Adil Rafiq Rather,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .
[32] Debashis Ghosh,et al. Penalized regression procedures for variable selection in the potential outcomes framework , 2015, Statistics in medicine.
[33] F. Kokturk,et al. Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia. , 2013, Journal of geriatric oncology.
[34] W. Ko,et al. Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[35] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[36] K. Sepkowitz,et al. Nosocomial infections in patients with cancer. , 2009, The Lancet. Oncology.
[37] G. Maschmeyer,et al. The epidemiology and treatment of infections in cancer patients. , 2008, International journal of antimicrobial agents.
[38] Stanley Lemeshow,et al. Assessing the Fit of the Model , 2005 .
[39] Rodney X. Sturdivant,et al. Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .
[40] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.